Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Carcinoma
|
0.300 |
Biomarker
|
group |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Animal Mammary Neoplasms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Mammary Neoplasms, Experimental
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Anaplastic carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Carcinoma, Spindle-Cell
|
0.300 |
Biomarker
|
disease |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Undifferentiated carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Carcinomatosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Mammary Carcinoma, Animal
|
0.300 |
Biomarker
|
disease |
CTD_human |
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
|
16316942 |
2005 |
Parkinson Disease
|
0.210 |
AlteredExpression
|
disease |
BEFREE |
In this study, we evaluated the changes in PTN and Fyn protein levels and Fyn phosphorylation status in the 6-OHDA rat model of PD rendered dyskinetic with L-DOPA.
|
29241709 |
2018 |
Parkinson Disease
|
0.210 |
Therapeutic
|
disease |
RGD |
Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.
|
19615368 |
2009 |
Liver Cirrhosis
|
0.210 |
AlteredExpression
|
disease |
LHGDN |
Pleiotrophin inhibits transforming growth factor beta1-induced apoptosis in hepatoma cell lines.
|
18381592 |
2008 |
Liver Cirrhosis
|
0.210 |
Biomarker
|
disease |
RGD |
Pleiotrophin inhibits transforming growth factor beta1-induced apoptosis in hepatoma cell lines.
|
18381592 |
2008 |
Left Ventricular Hypertrophy
|
0.200 |
Biomarker
|
disease |
RGD |
Intramyocardial protein therapy with vascular endothelial growth factor (VEGF-165) induces functional angiogenesis in rat senescent myocardium.
|
21224495 |
2010 |
Cholestasis, Extrahepatic
|
0.200 |
Biomarker
|
disease |
RGD |
Factors released from cholestatic rat livers possibly involved in inducing bone marrow hepatic stem cell priming.
|
18225978 |
2008 |
Sciatic Neuropathy
|
0.200 |
Biomarker
|
disease |
RGD |
Different pattern of pleiotrophin and midkine expression in neuropathic pain: correlation between changes in pleiotrophin gene expression and rat strain differences in neuropathic pain.
|
18365878 |
2008 |
Myocardial Infarction
|
0.200 |
Biomarker
|
disease |
RGD |
Conversely, we show in a rat model of myocardial infarction and in human dilated cardiomyopathy that pleiotrophin is markedly up-regulated.
|
17925408 |
2007 |
Transient Ischemic Attack
|
0.200 |
Biomarker
|
disease |
RGD |
Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury.
|
9570800 |
1998 |
Experimental Autoimmune Encephalomyelitis
|
0.200 |
Biomarker
|
disease |
RGD |
Basal expression of PTN and MK mRNAs in normal spinal cords was significantly upregulated after induction of EAE.
|
9814819 |
1998 |
Visual seizure
|
0.200 |
Biomarker
|
disease |
RGD |
Developmentally regulated expression of pleiotrophin, a novel heparin binding growth factor, in the nervous system of the rat.
|
8453763 |
1993 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
For example, circRNA_PTN has been recognized as a biomarker of human cancer and is overexpressed in glioma.
|
31609809 |
2020 |
Glioma
|
0.100 |
Biomarker
|
disease |
BEFREE |
For example, circRNA_PTN has been recognized as a biomarker of human cancer and is overexpressed in glioma.
|
31609809 |
2020 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
For example, circRNA_PTN has been recognized as a biomarker of human cancer and is overexpressed in glioma.
|
31609809 |
2020 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Pleiotrophin (PTN) is involved in tumour progression, angiogenesis and metastasis.
|
30635982 |
2019 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.
|
30427932 |
2018 |